Latest news with #PostgraduateInstituteofMedicalEducationandResearch
India.com
3 days ago
- Health
- India.com
PGIMER B.Sc Nursing Results 2025 DECLARED At pgimer.edu.in- Check Direct Link, Important Dates Here
PGIMER Nursing Results 2025: The Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh has officially released the results for the four-year and post basic Nursing Entrance Examinations 2025. All the candidates who have appeared for the exam can now check their result through the official website, i.e. Candidates must note that they will have to enter their information like their USER ID and password to access their result. And those who will clear the exam will be proceeded towards the next phase, i.e. counselling process PGIMER Nursing Results 2025: Important Dates Candidates must note that the document verification for Nursing (Post Basic) is scheduled for 11th August, 2025, from 9 AM, followed by counselling for the same course on 12th August, 2025, starting at 11 AM. For Nursing (4 Years), document verification will take place on 13th August, 2025, from 9 AM, and again on 14th August, 2025, from 11 AM. It is worth noting that the entrance examination for these courses was held on 27th July, 2025, while the admit cards were issued on 19th July, 2025. PGIMER Nursing Results 2025: Steps to Check the Result Step 1: Go to the official website- Step 2: You will find the link of Nursing Results 2025 on the homepage, click on it. Step 3: A new page will be opened on your screen to login in. Step 4: Enter the required details like your user id and password correctly and then submit it. Step 5: After submission, your result will appear on the screen. Step 6: Check the result and download the page for future reference. All the candidates are advised to keep checking the official website for all the important updates.
Hindustan Times
3 days ago
- Health
- Hindustan Times
PGIMER B.Sc Nursing Results 2025 declared, direct link to download scorecard here
The Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh has released the results of four-year and post basic nursing entrance examinations 2025. Candidates who appeared in the examination can check and download the scorecard from the official website at PGIMER Nursing Results 2025 are out. Candidates can download their results via the direct link here. Candidates will need to enter their USER ID and PASSWORD to check their results. Candidates who have qualified in the examination will now proceed for the first phase counselling process. As per the official schedule, following are some of the important dates to remember: Document verification of Nursing (Post Basic): August 11, 2025, from 9 AM. Counseling of Nursing (Post Basic): August 12, 2025, from 11 AM. Document verification of Nursing (4 years): August 13, 2025, from 9 AM. Document verification of Nursing (4 years): August 14, 2025, from 11 AM. It may be mentioned here that the entrance examinations were conducted on July 27, 2025. The admit cards were released on July 19, 2025. PGIMER Nursing Results 2025: How to download Candidates can follow the steps mentioned below to check their results: Visit the official website at On the home page, click on the link to check the Nursing Results 2025. Enter your credentials to log in, and submit. Check your result displayed on the screen. Download and keep a printout of the result for future reference. For more details, candidates are advised to visit the official website of PGIMER.
Time of India
03-08-2025
- Health
- Time of India
PGI's Rs 490 cr Advanced Neuroscience Centre nears launch by Sept
Chandigarh: India's healthcare system, currently facing a critical shortage of neurologists—with just one specialist available per million people—is on the brink of a major breakthrough. The Postgraduate Institute of Medical Education and Research (PGI), Chandigarh, is preparing to launch its long-awaited Advanced Neuroscience Centre, a Rs 490 crore project that promises to revolutionise neurological and neurosurgical care across the country. Approved in 2017 and with construction beginning in 2020, the centre is now nearing full operationalisation. PGI officials have confirmed that the outpatient department (OPD) is expected to become functional by September, marking a significant milestone in the journey to improve access to specialised brain and spine treatment. Once fully operational, the centre will join the ranks of premier institutions like NIMHANS Bengaluru and AIIMS Delhi's Cardiothoracic and Neurosciences Centre. However, PGI's facility stands out for its integrated model, combining neurology and neurosurgery services under one roof. "This will be the largest such centre in India where both specialities are housed in a single building," said a PGI official. "Beds will be consolidated, not scattered across departments, ensuring seamless care for patients. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Access all TV channels anywhere, anytime Techno Mag Learn More Undo " The project has faced several hurdles over the years. Construction was halted during the Covid pandemic in March, 2020 and resumed with limited labour by June. More recently, delays were caused by the renewal of pollution control clearance from the state pollution control board and the calculation of property tax arrears owed by PGI. Despite these challenges, the administration remains optimistic about the centre's phased rollout. The facility will feature 300 general ward beds, 10 modular operating theatres, dedicated ICUs, 10 High Dependency Unit (HDU) beds, and 30 private ward beds. It will offer advanced sub-specialities such as cerebrovascular surgery, skull base surgery, and spinal functional neurosurgery. A key highlight is the Brain Suite, a specialised operating room designed for complex neurosurgical procedures. While some equipment requests—like a 3T MRI, Bi-plane DSA, and dual-energy CT scan—were scaled down due to budget constraints, PGI faculty believe the centre will still significantly enhance diagnostic and treatment capabilities. "Patients come from all corners of India because of the expertise and affordability PGI offers," said a senior faculty member. The Advanced Neuroscience Centre is expected to serve as a national hub for neurological care, addressing a long-standing gap in specialised treatment. With its integrated approach and cutting-edge infrastructure, the centre is poised to offer a lifeline to thousands of patients who currently struggle to access timely and affordable brain and spine care. Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !
Indian Express
03-08-2025
- Health
- Indian Express
Rewriting diabetes: PGI study shows remission achievable
For decades, Type 2 diabetes has been viewed as a lifelong, irreversible condition, requiring daily medication, strict dietary control, and constant lifestyle management, but new hope is emerging from India's Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, where a clinical study has shown that remission may be possible through a carefully designed and practical strategy. Type 2 diabetes, which affects millions globally and has become a growing health concern in India, has long been seen as a chronic disease without a cure. Patients are often told they must manage it for life, with pills and blood sugar logs becoming permanent companions, but what if there is a chance to hit reset? Remission is the term scientists are now using, meaning a return to normal blood sugar levels with HbA1c of 6.5% without any diabetes medication for at least three months. However, a made-in-India approach with global promise led by Dr Rama Walia, a team of researchers at PGIMER, launched the DiaRem-1 study, aiming to explore whether tight blood sugar control using modern medicines, combined with lifestyle changes, could push the disease into remission. What makes their work stand out is that it does not rely on extreme weight loss diets or costly surgeries, which are often impractical for many patients. They selected adults diagnosed with Type 2 diabetes in the past five years, whose blood sugar was still reasonably controlled. For three months, these participants were placed on a combination of proven diabetes medications and guided through diet and physical activity. After that, all medications were stopped, and for the following three months, researchers monitored whether their blood sugar levels could remain in the normal range, drug-free. What happened? The results were eye-opening: about one in three participants (31%) achieved diabetes remission, meeting the internationally defined benchmark of maintaining HbA1c below 6.5% without medication for at least three months. Surprisingly, both treatment groups, one using newer medications like liraglutide and dapagliflozin, and the other using more commonly available medicines like glimepiride and vildagliptin, saw similar remission rates. Weight loss helped, but wasn't everything The average weight loss was modest, 4.7 kg in the intervention group and 3 kg in controls. MRI scans in select participants showed dramatic declines in internal fat stores, a 51% drop in liver fat and 48% in pancreatic fat, which are crucial contributors to insulin resistance and worsening diabetes. The science behind the strategy Doctors now understand that two major culprits drive diabetes progression: glucotoxicity (too much sugar damaging beta cells) and lipotoxicity (fat accumulation impairing insulin action). By reversing these with medication and lifestyle therapy, the pancreas gets a much-needed break and, in some cases, begins to function more normally again. Those who achieved remission also had better beta-cell function (as measured by a 'disposition index') and lower levels of insulin resistance (HOMA-IR) compared to those who didn't. Importantly, no single patient characteristic, age, weight, or the duration of diabetes could predict who would succeed, making this approach potentially applicable to a wide range of patients in early stages of diabetes. Side effects and safety: Well-tolerated treatment Minor side effects like nausea were seen, especially in those taking liraglutide, but there were no serious health risks noted. Notably, no patients in the intervention group experienced low blood sugar, a common concern with diabetes medications. A moment of change, not a cure Experts caution that remission is not the same as being cured. Blood sugar levels can rise again without ongoing lifestyle commitment, but the fact that normal levels can be sustained without medication, even temporarily, is a major breakthrough. What's Next? PGIMER's team is continuing research to test how long this remission lasts and whether longer treatment duration might improve outcomes further. But even now, this small but powerful trial offers a cost-effective and scalable strategy that can work in outpatient clinics across India and the world. 'With early, intensive treatment and continued support, many patients may no longer need diabetes medication. That's a powerful message of hope,' said Dr Walia, the lead investigator of the study. 'If you or someone you care about was recently diagnosed with Type 2 diabetes, this study brings an encouraging message: your condition may not be permanent. With early action, close follow-up, and guided treatment, remission is possible, and potentially within reach for many.'
Indian Express
03-08-2025
- Health
- Indian Express
PGI wins Best ROTTO Award for consecutive second year
Reinforcing its national leadership in the field of cadaver organ donation, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, has once again emerged as a trailblazer, clinching the prestigious Best ROTTO Award for the second consecutive year, marking its third national win since the inception of the award in 2019. The accolade was presented at the 15th Indian Organ Donation Day celebrations held at Dr BR Ambedkar International Centre in New Delhi under the aegis of the National Organ & Tissue Transplant Organisation (NOTTO) on Saturday. Union Minister for Health & Family Welfare Jagat Prakash Nadda was the chief guest at the event. The award was received by a delegation led by PGI Director Prof Vivek Lal. The Institute was also honoured with the award for the Best Brain Stem Death (BSD) Declaration Team, recognising the institute's unwavering adherence to transparent, timely and ethically sound donor identification and management protocols.
